The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What’s current and what’s next in Hodgkin lymphoma?

Sep 23, 2020

During the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the Lymphoma Hub spoke to David J. Straus, Memorial Sloan Kettering Cancer Center, New York, US. We asked: What’s current and what’s next in Hodgkin lymphoma?

What’s current and what’s next in Hodgkin lymphoma?

David J. Straus covers radio- and chemotherapy-based approaches, and outlines a number of novel drug classes that have demonstrated favorable responses in patients with Hodgkin lymphoma.


Your opinion matters

At this year’s virtual ESH Meeting, the Lymphoma Hub Satellite Symposium will evaluate treatment options in patients with R/R DLBCL. What do you think is the most promising emerging therapy in this setting?
4 vote s - 16 hours left ...

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month